""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" 'Best Hospital' in four specialties ""
""

""
"" New Birth Defect Expert ""
""

""
"" Tumor response may not be best measure ""
""

""
  Assessment of children with autism launched  
""

""
  New drug extends lung cancer survival  
""

""
  Grape seed extract may reduce blood pressure  
""

""
  Thimerosal linked with immune system dysfunction  
     
  Apples' protective ways identified  
     
  Molecule that targets leukemia, lymphoma cells found  
     
  Better, safer test for pernicious anemia  
     
  Smoking impact on Asians greater than realized  
     
  Bariatric program awarded center of excellence  
     
  Telemedicine program honored  
Vertical Seperator Line
""
""
NEWS
""
""
"" ""
"" ""
 
""

New drug extends lung cancer survival

 "" PHOTO — Assistant Professor Angela Davies
  ""
Assistant Professor Angela Davies
"" ""

Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according to final results from a Southwest Oncology Group study, led by UC Davis Cancer Center researchers. In the study, patients taking bortezomib plus gemcitabine and carboplatin had a median survival of 11 months, compared to nine months in past SWOG trials, reported Angela Davies, an assistant professor of hematology and oncology at UC Davis Cancer Center and lead author of the study.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

ucdavismedicine@ucdmc.ucdavis.edu

© 2006 UC Regents. All Rights Reserved.

"" "" ""